REGN5093-M114
Product Specifications
Target
C-Met/HGFR, Antibody-Drug Conjugates (ADCs), Microtubule Associated
Related Pathways
Antibody-drug Conjugate/ADC Related, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors
Bioactivity
REGN5093-M114 is a bispecific antibody-drug conjugate (ADC) that targets two epitopes of the MET receptor tyrosine kinase, effectively inhibiting NSCLC cell proliferation and demonstrating antitumor activity in mouse models. REGN5093-M114 is composed of the human monoclonal anti-MET antibody Davutamig and a tubulin-inhibiting linker-payload.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2951-100 1x 100 µL
CDX2 (GI Epithelial Marker) (CDX2/2951R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881942-500 1x 500 µL
S100A1 (Melanoma Marker) (S100A1/1942), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040769-500 1x 500 µL
P27 / KIP1 (KIP1/769), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details